247 related articles for article (PubMed ID: 36297149)
1. Global Prevalence of Colistin Resistance in
Uzairue LI; Rabaan AA; Adewumi FA; Okolie OJ; Folorunso JB; Bakhrebah MA; Garout M; Alfouzan WA; Halwani MA; Alamri AA; Halawani SA; Alshahrani FS; Hasan A; Mutair AA; Alhumaid S; Etafo J; Utip I; Odoh IM; Uwaezuoke NS
Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297149
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and mortality outcome of carbapenem- and colistin-resistant
Balkhair A; Saadi KA; Adawi BA
IJID Reg; 2023 Jun; 7():1-5. PubMed ID: 36936715
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis.
Narimisa N; Goodarzi F; Bavari S
Ann Clin Microbiol Antimicrob; 2022 Jun; 21(1):29. PubMed ID: 35765073
[TBL] [Abstract][Full Text] [Related]
4. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study.
Quan J; Li X; Chen Y; Jiang Y; Zhou Z; Zhang H; Sun L; Ruan Z; Feng Y; Akova M; Yu Y
Lancet Infect Dis; 2017 Apr; 17(4):400-410. PubMed ID: 28139430
[TBL] [Abstract][Full Text] [Related]
6. Colistin monotherapy or combination for the treatment of bloodstream infection caused by Klebsiella pneumoniae: a systematic review and meta-analysis.
Wang T; Liu H; Huang H; Weng Y; Wang X
BMC Infect Dis; 2024 Feb; 24(1):161. PubMed ID: 38317132
[TBL] [Abstract][Full Text] [Related]
7. Pattern of colistin resistance in Klebsiella isolates in an Intensive Care Unit of a tertiary care hospital in India.
Sodhi K; Mittal V; Arya M; Kumar M; Phillips A; Kajla B
J Infect Public Health; 2020 Jul; 13(7):1018-1021. PubMed ID: 31818712
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Mutated Colistin-Resistant
Yusof NY; Norazzman NII; Hakim SNWA; Azlan MM; Anthony AA; Mustafa FH; Ahmed N; Rabaan AA; Almuthree SA; Alawfi A; Alshengeti A; Alwarthan S; Garout M; Alawad E; Yean CY
Trop Med Infect Dis; 2022 Dec; 7(12):. PubMed ID: 36548669
[TBL] [Abstract][Full Text] [Related]
9. KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?
Antochevis LC; Magagnin CM; Nunes AG; Goulart TM; Martins AS; Cayô R; Gales AC; Barth AL; Zavascki AP
J Glob Antimicrob Resist; 2018 Dec; 15():173-177. PubMed ID: 30071353
[TBL] [Abstract][Full Text] [Related]
10. Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant
El-Mahallawy HA; El Swify M; Abdul Hak A; Zafer MM
Ann Med; 2022 Dec; 54(1):1-9. PubMed ID: 36373970
[TBL] [Abstract][Full Text] [Related]
11. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the in vitro activity of ceftazidime/avibactam against a global collection of multidrug-resistant Klebsiella spp. from the INFORM surveillance programme (2015-2017).
Rossolini GM; Stone GG
Int J Antimicrob Agents; 2020 Sep; 56(3):106111. PubMed ID: 32721602
[TBL] [Abstract][Full Text] [Related]
13. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
[TBL] [Abstract][Full Text] [Related]
14. Clinical carbapenem-resistant
Shahid M; Ahmad N; Saeed NK; Shadab M; Joji RM; Al-Mahmeed A; Bindayna KM; Tabbara KS; Dar FK
Front Cell Infect Microbiol; 2022; 12():1033305. PubMed ID: 36304935
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
16. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Demirlenk YM; Gücer LS; Uçku D; Tanrıöver C; Akyol M; Kalay Z; Barçın E; Akcan RE; Can F; Gönen M; Ergönül Ö
Eur J Clin Microbiol Infect Dis; 2022 May; 41(5):761-769. PubMed ID: 35303195
[TBL] [Abstract][Full Text] [Related]
18.
Goel A; Gupta V; Singhal L; Palta S; Chander J
Indian J Med Res; 2021 Mar; 154(3):520-526. PubMed ID: 35345078
[TBL] [Abstract][Full Text] [Related]
19. Emergence of the Novel Aminoglycoside Acetyltransferase Variant
Sato T; Wada T; Nishijima S; Fukushima Y; Nakajima C; Suzuki Y; Takahashi S; Yokota SI
mBio; 2020 Dec; 11(6):. PubMed ID: 33443109
[TBL] [Abstract][Full Text] [Related]
20. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
